合作類型：技術  行業(yè)類別: 生物科學與健康  過期時間：2017年05月25日    

一家加泰羅尼亞的公司正在尋找擁有新的治療肺結核或者潛伏性肺結核的化療方法的機構。這種新的化療方法能夠在效率上、管理方法上對比現(xiàn)有化療方法有提高。該公司也需要治療抗多種抗菌素的肺結核的治療方法。他們希望與機構達成技術購買、許可證協(xié)議以及其他各種形式的合作。

英語原文：

Summary:

A Catalan company is looking for new chemotherapeutic agent in the treatment of Tuberculosis, active and/or latent Tuberculosis. The new treatment should represent an advantage over the current treatments, for example in terms of efficacy, improvement of administration, etc.

New treatments for (multiresistant tuberculosis) are also desirable. Technologies for acquisition, license and/or other types of collaborations are sought.

Details:

Tuberculosis is a very important disease, which has increased its prevalence in the last years.

The current chemotherapeutical agents are very old and with a lot of side effects. Furthermore the treatments must be very long and it is very difficult for patients to follow the compliance to the treatment.

On the other hand, in a very high percentage of patients after finishing the treatment the disease remains latent, without symptoms, but with a high possibility to be transmitted.

In other cases and certain types of tuberculosis it is seen a multiresistant behavior in front of the current existing treatments.

So, new chemotherapeutical agents are needed in terms of increasing efficacy, reduce side effects, reduce the time of treatments o reduce the multiresistant effect.

The Catalan company is looking for a company making research in this field to stablish an international cooperation, which can be acquisition agreement, joint-venture agreement, license agreement, research cooperation agreement or subcontracting.

Type and Role of Partners Sought: